Completed

The ICHOM Set of Patient-Centered Outcome Measures for Depression & Anxiety is the result of hard work by a group of leading physicians, measurement experts, and patients. It represents the outcomes that matter most to patients with depression and/or anxiety. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.

  1. Recommended to track via the Patient Health Questionnaire (PHQ-9).
  2. Includes symptoms of general anxiety, social phobia, agoraphobia, post-traumatic stress disorder, panic disorder, and obsessive-compulsive disorder.
  3. Recommended to track via the Generalized Anxiety Disorder (GAD-7), and for those with specific anxiety disorders: the Social Phobia Inventory (SPIN), the Mobility Inventory for Agoraphobia (MIA), the Impact of Event Scale – Revised for Post-Traumatic Stress Disorder (IES-R), the Panic Disorder Severity Scale (PDSS-SR), and the Obsessive-Compulsive Inventory (OCI-R).
  4. Recommended to track via the World Health Organization Disability Assessment 2.0 (WHODAS 2.0).
  5. Includes work status and disease-related absenteeism.

Premium Content

Enter your details below to gain access to this content.
Please note: You will need to enable cookies to download premium content

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
ICHOM Accreditation Product Logo

All of the basic information you need to implement ICHOM Sets is available in the links above. However, for a faster, more easily integrated process, we offer digitised versions of the Set measures. These are designed for immediate upload to existing EMR systems. This is available as part of our Accreditation package, which recognises your work in putting patient outcomes at the heart of treatment.

Find Out More

Team that developed this set

AUSTRALIA
Maria Kangas | Centre for Emotional Health, Macquarie University

BRAZIL
Roberta Alvarenga Reis | Universidade Federal do Rio Grande do Sul

CANADA
Anne Crocker | Douglas Mental Health University Institute, McGill University
Lucie Langford*
Alain Lesage | University of Montreal

CHILE
Graciela Rojas | University of Chile

GERMANY
Sandra Nolte | Charité Universitätsmedizin Berlin
Alexander Obbarius | Charité Universitätsmedizin Berlin
Matthias Rose | Charité Universitätsmedizin Berlin

INDIA
Vikram Patel | London School of Hygiene and Tropical Medicine

JAPAN
Toshi A. Furukawa | Kyoto University

NETHERLANDS
Edwin de Beurs | Stichting Benchmark GGZ
Paul Emmelkamp | University of Amsterdam

SWEDEN
Erik Hedman | Karolinska Institutet

UGANDA
Doris M. Mwesigire | Makerere University

UNITED KINGDOM
David M. Clark | University of Oxford
David Smithson* | Anxiety UK

UNITED STATES
Lee Baer | Harvard Medical School; Massachusetts General Hospital
Kelly Woolaway-Bickel | Department of the U.S. Army, Office of the Surgeon General
Paul A. Pilkonis | University of Pittsburgh
Harold A. Pincus | Columbia University
Cathy Sherbourne | The RAND Corporation

* Patient representative

Are you implementing ICHOM Sets?

If your are implementing ICHOM Sets, please help us understand more about your journey by filling in our Implementation Survey. Click on the link below to complete:

View Survey

Implementation Map

We would like to add you to our Implementation Map if you are implementing or have implemented ICHOM Sets. Please click on the button below for more information.

Find Out More